Stoke Therapeutics, Inc. (STOK) dividend history
STOKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30173% above fair value
$26.41−0.22 (-0.83%)
Close on Nov 17, 2026Market cap $1.70BP/E –Yield –
Dividends
Stoke Therapeutics has not reported a dividend
No dividend per share appears in Stoke Therapeutics's annual filings since fiscal 2017.
See a number that looks wrong?